Medasorb Technologies Corporation (SBT) Reports Q4 EPS of $0.13

Medasorb Technologies Corporation (NASDAQ: SBT) reported Q4 EPS of $0.13, versus $0.21 reported last year.

Q4 2017 Summary

• Total portfolio loans of $2.59 billion, a 31% year-over-year increase
• Total deposits of $2.25 billion, a 39% year-over-year increase
• Net income of $6.5 million, or $0.13 diluted EPS, including a non-cash charge of $3.3 million recorded to tax expense relating to the recently enacted tax reform
• Net interest margin of 3.97%
• Successfully completed initial public offering with a total offering size of over $200 million, with net proceeds of over $85 million to the Company

For earnings history and earnings-related data on Medasorb Technologies Corporation (SBT) click here.

You May Also Be Interested In

• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c